Kala Pharmaceuticals Inks $11.5M in Series A - VC News Daily
Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat a wide range of debilitating diseases, announced today …
OFF
Kala Pharmaceuticals Inks $11.5M In Series A - VC News Daily
1 week from now
Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat a wide range of debilitating diseases, announced today …
vcnewsdaily.com
OFF
Investors Cough Up $11.5M For Kala Pharmaceuticals
1 week from now
Kala Pharmaceuticals, a Waltham, MA-based developer of treatments for diseases affecting mucosal tissues, has secured $11.5 million in Series A financing.The company will use the …
pitchbook.com
OFF
Kala Pharmaceuticals Secures $11.5m Series A - Venture Capital …
1 week from now
Feb 28, 2013 · Kala Pharmaceuticals has secured $11.5 million in Series A equity financing through new and existing investors. New and lead investor Crown Venture Fund the venture …
venturecapitaljournal.com
OFF
Kala Pharmaceuticals Secures $11.5 Million In Series A Financing
1 week from now
Feb 28, 2013 · ©2024 KALA BIO All rights reserved. September 2024. Terms of Use Privacy Statement
kalarx.com
OFF
Kala Pharmaceuticals Raises $11.5M In Series A Equity Financing
1 week from now
Feb 28, 2013 · Kala Pharmaceuticals, a Waltham, MA-based developer of innovative products that treat a wide range of debilitating diseases by penetrating the mucosal barrier, raised …
finsmes.com
OFF
Kala Pharmaceuticals - Raised $115M Funding From 16 Investors
1 week from now
Nov 5, 2024 · Kala Pharmaceuticals has raised a total funding of $115M over 11 rounds from 16 investors. Investors include Athyrium Capital Management, Vivo Capital and 14 others. ...
tracxn.com
OFF
Kala Pharmaceuticals Has Received $11.5m In Series A Equity …
1 week from now
Tags: Kala Pharmaceuticals, drugs, ocular diseases drugs Kala Pharmaceuticals, a developer of products that effectively penetrate the mucosal barrier to treat various debilitating diseases, …
made-in-china.com
OFF
Kala Pharmaceuticals - Raised $115M Funding From 16 Investors
1 week from now
Kala Pharmaceuticals has raised a total funding of $115M over 10 rounds from 16 investors. Investors include Polaris Partners, Orbimed and 14 others. Their latest funding round was of …
tracxn.com
OFF
Series A - Kala Pharmaceuticals - 2013-02-28 - Crunchbase
1 week from now
Feb 28, 2013 · Kala Pharmaceuticals raised $11500000 on 2013-02-28 in Series A. Crown Venture Fund Crown Venture Fund is an investment company specialized in early stage …
crunchbase.com
OFF
Kala Pharmaceuticals - Company Profile - Tracxn
1 week from now
Oct 22, 2024 · Kala Pharmaceuticals - Developer of ophthalmic treatments based on its mucosal penetrating product platform. Public Company. Raised a total funding of $115M over 11 …
tracxn.com
OFF
KALA BIO, Inc. (KALA) Stock Price, Quote & News - Stock Analysis
1 week from now
4 days ago · Kala Pharmaceuticals stock up 750% in 3 days after upbeat FDA news on PCED treatment. Shares of Kala Pharmaceuticals Inc. KALA, +39.53% have rocketed higher in for …
stockanalysis.com
OFF
Kala Pharmaceuticals Inc. (KALA) Stock Price, News & Historical Data
1 week from now
Jul 20, 2017 · Kala Pharmaceuticals Joins NASDAQ, the Biotech IPOs Keep Coming. After offering six million shares, the stock was up 18% to $17.70. KALA.
thestreet.com
OFF
Kala Pharmaceuticals Inks $22.5M Series B - VC News Daily
1 week from now
Kala Pharmaceuticals Inks $22.5M Series B. Back to Home. 2014-04-23. Tweet. WALTHAM, MA, Leading developer of innovative ophthalmic products has completed a $22.5 million Series B …
vcnewsdaily.com
OFF
Kala Pharmaceuticals Closes $68M In Series C - Vcnewsdaily.com
1 week from now
Kala Pharmaceuticals Inc., a developer of ophthalmic products based on muscle-penetrating particle technology, has raised $68 million in Series C funding. Longitude Capital led the …
vcnewsdaily.com
OFF
Checkmate Pharmaceuticals Inks $85M In Series C - VC News Daily
1 week from now
Jun 10, 2020 · Checkmate Pharmaceuticals (Checkmate), a clinical stage biotechnology company focused on improving patients' lives with its novel approach to cancer immunotherapy, …
vcnewsdaily.com
OFF
Akero Therapeutics Inks $70M In Series B - VC News Daily
1 week from now
Akero Therapeutics, Inc., a biotechnology company developing transformational treatments for non-alcohol steatohepatitis (NASH) and other serious metabolic diseases, today announced …
vcnewsdaily.com
FAQs about Kala Pharmaceuticals Inks $11.5M in Series A - VC News Daily Coupon?
Why did Kala Pharmaceuticals stock surge Wednesday?
Why did Kala submit a drug application?
Does Kala have a kpi-012 drug application?
Where can I find more information about Kala?
Does Kala bio offer non-statutory stock options?
Did Kala give a new employee non-statutory stock options?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
